Histogen (HSTO)
(Delayed Data from OTC)
$0.21 USD
0.00 (0.00%)
Updated Oct 16, 2024 12:31 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Histogen Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 4 | 1 | 2 | 22 |
Cost Of Goods | NA | 0 | 0 | 1 | 0 |
Gross Profit | NA | 4 | 1 | 1 | 22 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 14 | 16 | 20 | 34 |
Income After Depreciation & Amortization | 0 | -11 | -15 | -19 | -12 |
Non-Operating Income | NA | 0 | 0 | 0 | 1 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | NA | -11 | -15 | -19 | -11 |
Income Taxes | NA | 0 | 0 | 0 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -11 | -15 | -19 | -11 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -11 | -15 | -19 | -11 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -11 | -15 | -19 | -12 |
Depreciation & Amortization (Cash Flow) | NA | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | 0 | -11 | -15 | -19 | -12 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | 3.21 | 1.92 | 0.45 | 0.17 |
Diluted EPS Before Non-Recurring Items | NA | -3.46 | -7.80 | -20.40 | -68.00 |
Diluted Net EPS (GAAP) | NA | -3.46 | -7.80 | -41.60 | -68.00 |
Fiscal Year end for Histogen Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | 0.01 |
Cost Of Goods | NA | NA | NA | NA | 0.00 |
Gross Profit | NA | NA | NA | NA | 0.01 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 3.53 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -3.52 |
Non-Operating Income | NA | NA | NA | NA | -0.33 |
Interest Expense | NA | NA | NA | NA | 0.00 |
Pretax Income | NA | NA | NA | NA | -3.85 |
Income Taxes | NA | NA | NA | NA | 0.00 |
Minority Interest | NA | NA | NA | NA | 0.00 |
Investment Gains/Losses | NA | NA | NA | NA | 0.00 |
Other Income/Charges | NA | NA | NA | NA | 0.00 |
Income From Cont. Operations | NA | NA | NA | NA | -3.85 |
Extras & Discontinued Operations | NA | NA | NA | NA | 0.00 |
Net Income (GAAP) | NA | NA | NA | NA | -3.86 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | 4.27 |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | -0.90 |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | -0.90 |